Acadia Healthcare Company, Inc. - COMMON STOCK (ACHC)

Historical Holders from Q1 2014 to Q1 2025

Symbol
ACHC on Nasdaq
CUSIP
00404A109
Type / Class
Equity / COMMON STOCK
Shares outstanding
93M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
100M
Holdings value
$3.98B
% of all portfolios
0.01%
Grand Portfolio weight change
0%
Number of holders
303
Number of buys
172
Number of sells
-162
Average Value change %
+0%
Average buys %
+0.007%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Acadia Healthcare Company, Inc. - COMMON STOCK (ACHC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 6.7% $180M 6.23M FMR LLC Dec 31, 2024

Institutional Holders of Acadia Healthcare Company, Inc. - COMMON STOCK (ACHC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 531K $16.1M -$46.2M $30.32 20
2024 Q4 100M $3.98B -$243M $39.65 303
2024 Q3 98.3M $6.23B +$94.5M $63.41 309
2024 Q2 96.7M $6.53B +$228M $67.54 303
2024 Q1 93.2M $7.38B +$36.2M $79.22 313
2023 Q4 92M $7.15B +$67.3M $77.76 302
2023 Q3 90.2M $6.34B -$123M $70.31 285
2023 Q2 91.8M $7.31B -$2.12M $79.64 273
2023 Q1 91.4M $6.6B +$106M $72.25 301
2022 Q4 90M $7.41B -$97.2M $82.32 336
2022 Q3 92.1M $7.21B -$761M $78.18 305
2022 Q2 89.6M $6.06B +$124M $67.63 265
2022 Q1 86.7M $5.68B +$8M $65.53 276
2021 Q4 90.1M $5.47B -$3.09M $60.70 267
2021 Q3 90.2M $5.75B +$11.6M $63.78 286
2021 Q2 90M $5.64B -$37.8M $62.75 281
2021 Q1 90.5M $5.17B +$18M $57.14 266
2020 Q4 90.6M $4.55B -$106M $50.26 257
2020 Q3 90.6M $2.67B -$53.9M $29.48 213
2020 Q2 92.4M $2.32B -$55M $25.12 200
2020 Q1 97.6M $1.79B -$214M $18.35 196
2019 Q4 96.9M $3.22B -$31.6M $33.22 225
2019 Q3 104M $3.22B -$109M $31.08 212
2019 Q2 107M $3.75B +$48.5M $34.95 225
2019 Q1 107M $3.15B +$158M $29.31 240
2018 Q4 103M $2.65B -$80M $25.71 237
2018 Q3 105M $3.68B +$74.5M $35.20 239
2018 Q2 104M $4.24B -$249M $40.91 243
2018 Q1 109M $4.28B +$124M $39.18 230
2017 Q4 107M $3.5B -$269M $32.63 252
2017 Q3 112M $5.33B -$71.6M $47.76 258
2017 Q2 114M $5.61B +$348M $49.38 248
2017 Q1 110M $4.81B +$735M $43.60 223
2016 Q4 98.3M $3.25B +$99.6M $33.10 225
2016 Q3 92.8M $4.6B +$283M $49.55 249
2016 Q2 87.9M $4.87B +$187M $55.40 245
2016 Q1 84M $4.63B +$1.04B $55.11 233
2015 Q4 65.3M $4.08B +$115M $62.46 230
2015 Q3 63.1M $4.18B +$155M $66.27 245
2015 Q2 56.8M $4.45B +$181M $78.33 234
2015 Q1 58.7M $4.2B +$521M $71.60 203
2014 Q4 51.2M $3.14B -$19.3M $61.21 192
2014 Q3 49.3M $2.39B +$76.1M $48.50 171
2014 Q2 50.3M $2.29B +$423M $45.50 181
2014 Q1 40.7M $1.83B +$47.9M $45.12 160